Scibase AB (SCIB) - Cash Flow Conversion Efficiency

Latest as of December 2025: -3.129x

Based on the latest financial reports, Scibase AB (SCIB) has a cash flow conversion efficiency ratio of -3.129x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-20.82 Million ≈ $-2.24 Million USD) by net assets (Skr6.66 Million ≈ $716.29K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Scibase AB (SCIB) balance sheet quality index to measure how much of total assets are equity-financed.

Scibase AB - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Scibase AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore Scibase AB cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Scibase AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Scibase AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Orange County Bancorp Inc NASDAQ:OBT	0.106x
Genbyte Technology Inc SHE:003028	0.043x
SK Chemicals Co Ltd KO:285130	0.016x
Mstc Limited NSE:MSTCLTD	-0.209x
GULF KEYSTONE PETR. F:GVP1	N/A
Eastern & Oriental Bhd KLSE:3417	-0.010x
Nextensa NV BR:NEXTA	0.030x
Luxfer Holdings PLC NYSE:LXFR	-0.018x

Annual Cash Flow Conversion Efficiency for Scibase AB (2012–2025)

The table below shows the annual cash flow conversion efficiency of Scibase AB from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Scibase AB stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr6.66 Million ≈ $716.29K	Skr-84.58 Million ≈ $-9.10 Million	-12.707x	-711.59%
2024-12-31	Skr36.65 Million ≈ $3.94 Million	Skr-57.38 Million ≈ $-6.18 Million	-1.566x	-29.68%
2023-12-31	Skr43.06 Million ≈ $4.63 Million	Skr-51.98 Million ≈ $-5.59 Million	-1.207x	+31.48%
2022-12-31	Skr25.24 Million ≈ $2.72 Million	Skr-44.47 Million ≈ $-4.79 Million	-1.762x	-215.78%
2021-12-31	Skr70.80 Million ≈ $7.62 Million	Skr-39.50 Million ≈ $-4.25 Million	-0.558x	+22.78%
2020-12-31	Skr46.86 Million ≈ $5.04 Million	Skr-33.86 Million ≈ $-3.64 Million	-0.723x	+39.05%
2019-12-31	Skr32.01 Million ≈ $3.45 Million	Skr-37.96 Million ≈ $-4.08 Million	-1.186x	-126.10%
2018-12-31	Skr71.48 Million ≈ $7.69 Million	Skr-37.48 Million ≈ $-4.03 Million	-0.524x	-37.36%
2017-12-31	Skr115.72 Million ≈ $12.45 Million	Skr-44.18 Million ≈ $-4.75 Million	-0.382x	-47.93%
2016-12-31	Skr185.41 Million ≈ $19.95 Million	Skr-47.85 Million ≈ $-5.15 Million	-0.258x	-61.43%
2015-12-31	Skr291.42 Million ≈ $31.36 Million	Skr-46.59 Million ≈ $-5.01 Million	-0.160x	+85.92%
2014-12-31	Skr32.65 Million ≈ $3.51 Million	Skr-37.08 Million ≈ $-3.99 Million	-1.136x	-20.76%
2013-12-31	Skr36.18 Million ≈ $3.89 Million	Skr-34.03 Million ≈ $-3.66 Million	-0.940x	-161.14%
2012-12-31	Skr-23.69 Million ≈ $-2.55 Million	Skr-36.44 Million ≈ $-3.92 Million	1.538x	--

About Scibase AB

ST:SCIB Sweden Medical Devices

Market Cap

$3.27 Billion

Skr30.37 Billion SEK

Market Cap Rank

#12492 Global

#202 in Sweden

Share Price

Skr29.70

Change (1 day)

-0.34%

52-Week Range

Skr0.21 - Skr50.80

All Time High

Skr50.80